Glycoprotein VI-novel target in antiplatelet medication
O Borst, M Gawaz - Pharmacology & therapeutics, 2021 - Elsevier
Subendothelial collagen exposed to platelets after rupture of atherosclerotic plaques is the
main trigger of platelet activation und acute arterial thrombotic occlusion leading to …
main trigger of platelet activation und acute arterial thrombotic occlusion leading to …
[引用][C] Glycoprotein VI-novel target in antiplatelet medication
O Borst, M Gawaz - Pharmacology & Therapeutics, 2021 - ub01.uni-tuebingen.de
Glycoprotein VI - novel target in antiplatelet medication Glycoprotein VI - novel target in
antiplatelet medication DSpace Repositorium (Manakin basiert) Einloggen …
antiplatelet medication DSpace Repositorium (Manakin basiert) Einloggen …
[引用][C] Glycoprotein VI-novel target in antiplatelet medication
O Borst, M Gawaz - Pharmacology & Therapeutics, 2021 - tobias-lib.ub.uni-tuebingen.de
Glycoprotein VI - novel target in antiplatelet medication Glycoprotein VI - novel target in
antiplatelet medication DSpace Repositorium (Manakin basiert) Einloggen Publikationsdienste …
antiplatelet medication DSpace Repositorium (Manakin basiert) Einloggen Publikationsdienste …
Glycoprotein VI-novel target in antiplatelet medication
O Borst, M Gawaz - Pharmacology & therapeutics, 2021 - pubmed.ncbi.nlm.nih.gov
Subendothelial collagen exposed to platelets after rupture of atherosclerotic plaques is the
main trigger of platelet activation und acute arterial thrombotic occlusion leading to …
main trigger of platelet activation und acute arterial thrombotic occlusion leading to …
Glycoprotein VI-novel target in antiplatelet medication.
O Borst, M Gawaz - Pharmacology & Therapeutics, 2020 - europepmc.org
Subendothelial collagen exposed to platelets after rupture of atherosclerotic plaques is the
main trigger of platelet activation und acute arterial thrombotic occlusion leading to …
main trigger of platelet activation und acute arterial thrombotic occlusion leading to …